nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0784	0.282	CbGbCtD
Vardenafil—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0529	0.19	CbGbCtD
Vardenafil—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0505	0.182	CbGbCtD
Vardenafil—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.045	0.162	CbGbCtD
Vardenafil—PDE5A—pulmonary artery—chronic obstructive pulmonary disease	0.0337	0.432	CbGeAlD
Vardenafil—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0264	0.0949	CbGbCtD
Vardenafil—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0249	0.0896	CbGbCtD
Vardenafil—PDE10A—respiratory system—chronic obstructive pulmonary disease	0.00969	0.124	CbGeAlD
Vardenafil—PDE6G—lung—chronic obstructive pulmonary disease	0.00762	0.0976	CbGeAlD
Vardenafil—PDE5A—respiratory system—chronic obstructive pulmonary disease	0.00567	0.0727	CbGeAlD
Vardenafil—PDE10A—lung—chronic obstructive pulmonary disease	0.00515	0.066	CbGeAlD
Vardenafil—PDE5A—connective tissue—chronic obstructive pulmonary disease	0.00499	0.064	CbGeAlD
Vardenafil—Sildenafil—CYP1A1—chronic obstructive pulmonary disease	0.00489	1	CrCbGaD
Vardenafil—PDE5A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00457	0.0585	CbGeAlD
Vardenafil—PDE5A—lung—chronic obstructive pulmonary disease	0.00301	0.0386	CbGeAlD
Vardenafil—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.00236	0.0302	CbGeAlD
Vardenafil—CYP3A5—lung—chronic obstructive pulmonary disease	0.00125	0.016	CbGeAlD
Vardenafil—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000842	0.0018	CcSEcCtD
Vardenafil—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000842	0.0018	CcSEcCtD
Vardenafil—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000836	0.00179	CcSEcCtD
Vardenafil—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000836	0.00179	CcSEcCtD
Vardenafil—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00083	0.00178	CcSEcCtD
Vardenafil—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000826	0.00177	CcSEcCtD
Vardenafil—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00082	0.00176	CcSEcCtD
Vardenafil—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00082	0.00176	CcSEcCtD
Vardenafil—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000813	0.00174	CcSEcCtD
Vardenafil—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000813	0.00174	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00081	0.00173	CcSEcCtD
Vardenafil—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000803	0.00172	CcSEcCtD
Vardenafil—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.0008	0.00171	CcSEcCtD
Vardenafil—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00079	0.00169	CcSEcCtD
Vardenafil—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00079	0.00169	CcSEcCtD
Vardenafil—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00079	0.00169	CcSEcCtD
Vardenafil—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00079	0.00169	CcSEcCtD
Vardenafil—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00079	0.00169	CcSEcCtD
Vardenafil—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00079	0.00169	CcSEcCtD
Vardenafil—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00079	0.00169	CcSEcCtD
Vardenafil—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000787	0.00169	CcSEcCtD
Vardenafil—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000787	0.00169	CcSEcCtD
Vardenafil—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000787	0.00169	CcSEcCtD
Vardenafil—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000787	0.00169	CcSEcCtD
Vardenafil—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000786	0.00168	CcSEcCtD
Vardenafil—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000785	0.00168	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000784	0.00168	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000784	0.00168	CcSEcCtD
Vardenafil—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00078	0.00167	CcSEcCtD
Vardenafil—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00078	0.00167	CcSEcCtD
Vardenafil—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000774	0.00166	CcSEcCtD
Vardenafil—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000773	0.00166	CcSEcCtD
Vardenafil—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000773	0.00166	CcSEcCtD
Vardenafil—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000772	0.00165	CcSEcCtD
Vardenafil—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000772	0.00165	CcSEcCtD
Vardenafil—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000771	0.00165	CcSEcCtD
Vardenafil—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00077	0.00165	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000768	0.00165	CcSEcCtD
Vardenafil—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000767	0.00164	CcSEcCtD
Vardenafil—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000763	0.00163	CcSEcCtD
Vardenafil—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000757	0.00162	CcSEcCtD
Vardenafil—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000757	0.00162	CcSEcCtD
Vardenafil—Infection—Formoterol—chronic obstructive pulmonary disease	0.000752	0.00161	CcSEcCtD
Vardenafil—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000752	0.00161	CcSEcCtD
Vardenafil—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000746	0.0016	CcSEcCtD
Vardenafil—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000746	0.0016	CcSEcCtD
Vardenafil—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000746	0.0016	CcSEcCtD
Vardenafil—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000743	0.00159	CcSEcCtD
Vardenafil—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000742	0.00159	CcSEcCtD
Vardenafil—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000742	0.00159	CcSEcCtD
Vardenafil—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000741	0.00159	CcSEcCtD
Vardenafil—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000741	0.00159	CcSEcCtD
Vardenafil—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000739	0.00158	CcSEcCtD
Vardenafil—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000739	0.00158	CcSEcCtD
Vardenafil—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000737	0.00158	CcSEcCtD
Vardenafil—Infection—Montelukast—chronic obstructive pulmonary disease	0.000737	0.00158	CcSEcCtD
Vardenafil—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000735	0.00158	CcSEcCtD
Vardenafil—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000735	0.00158	CcSEcCtD
Vardenafil—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000733	0.00157	CcSEcCtD
Vardenafil—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000729	0.00156	CcSEcCtD
Vardenafil—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000727	0.00156	CcSEcCtD
Vardenafil—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00072	0.00154	CcSEcCtD
Vardenafil—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000715	0.00153	CcSEcCtD
Vardenafil—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00071	0.00152	CcSEcCtD
Vardenafil—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000707	0.00152	CcSEcCtD
Vardenafil—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000707	0.00152	CcSEcCtD
Vardenafil—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000704	0.00151	CcSEcCtD
Vardenafil—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000703	0.00151	CcSEcCtD
Vardenafil—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000701	0.0015	CcSEcCtD
Vardenafil—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000698	0.00149	CcSEcCtD
Vardenafil—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000694	0.00149	CcSEcCtD
Vardenafil—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000691	0.00148	CcSEcCtD
Vardenafil—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000691	0.00148	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00069	0.00148	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00069	0.00148	CcSEcCtD
Vardenafil—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000685	0.00147	CcSEcCtD
Vardenafil—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000685	0.00147	CcSEcCtD
Vardenafil—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00068	0.00146	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000675	0.00145	CcSEcCtD
Vardenafil—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000675	0.00145	CcSEcCtD
Vardenafil—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000675	0.00145	CcSEcCtD
Vardenafil—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000673	0.00144	CcSEcCtD
Vardenafil—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000673	0.00144	CcSEcCtD
Vardenafil—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000671	0.00144	CcSEcCtD
Vardenafil—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000668	0.00143	CcSEcCtD
Vardenafil—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000666	0.00143	CcSEcCtD
Vardenafil—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000666	0.00143	CcSEcCtD
Vardenafil—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000666	0.00143	CcSEcCtD
Vardenafil—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000664	0.00142	CcSEcCtD
Vardenafil—Injury—Prednisone—chronic obstructive pulmonary disease	0.000659	0.00141	CcSEcCtD
Vardenafil—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000659	0.00141	CcSEcCtD
Vardenafil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000658	0.00141	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000653	0.0014	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000653	0.0014	CcSEcCtD
Vardenafil—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000653	0.0014	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000651	0.0014	CcSEcCtD
Vardenafil—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000647	0.00139	CcSEcCtD
Vardenafil—Pain—Formoterol—chronic obstructive pulmonary disease	0.000647	0.00139	CcSEcCtD
Vardenafil—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000646	0.00139	CcSEcCtD
Vardenafil—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000645	0.00138	CcSEcCtD
Vardenafil—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000642	0.00138	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00064	0.00137	CcSEcCtD
Vardenafil—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000637	0.00137	CcSEcCtD
Vardenafil—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000635	0.00136	CcSEcCtD
Vardenafil—Pain—Montelukast—chronic obstructive pulmonary disease	0.000634	0.00136	CcSEcCtD
Vardenafil—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000634	0.00136	CcSEcCtD
Vardenafil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000632	0.00135	CcSEcCtD
Vardenafil—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00063	0.00135	CcSEcCtD
Vardenafil—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000629	0.00135	CcSEcCtD
Vardenafil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000627	0.00134	CcSEcCtD
Vardenafil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000626	0.00134	CcSEcCtD
Vardenafil—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000625	0.00134	CcSEcCtD
Vardenafil—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000624	0.00134	CcSEcCtD
Vardenafil—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000624	0.00134	CcSEcCtD
Vardenafil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000623	0.00133	CcSEcCtD
Vardenafil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00062	0.00133	CcSEcCtD
Vardenafil—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000619	0.00133	CcSEcCtD
Vardenafil—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000619	0.00133	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000617	0.00132	CcSEcCtD
Vardenafil—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000611	0.00131	CcSEcCtD
Vardenafil—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000606	0.0013	CcSEcCtD
Vardenafil—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000598	0.00128	CcSEcCtD
Vardenafil—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000598	0.00128	CcSEcCtD
Vardenafil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000596	0.00128	CcSEcCtD
Vardenafil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000591	0.00127	CcSEcCtD
Vardenafil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000591	0.00127	CcSEcCtD
Vardenafil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000591	0.00127	CcSEcCtD
Vardenafil—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000589	0.00126	CcSEcCtD
Vardenafil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000588	0.00126	CcSEcCtD
Vardenafil—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000586	0.00126	CcSEcCtD
Vardenafil—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000585	0.00125	CcSEcCtD
Vardenafil—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000584	0.00125	CcSEcCtD
Vardenafil—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00058	0.00124	CcSEcCtD
Vardenafil—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000577	0.00124	CcSEcCtD
Vardenafil—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000565	0.00121	CcSEcCtD
Vardenafil—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000558	0.00119	CcSEcCtD
Vardenafil—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000558	0.00119	CcSEcCtD
Vardenafil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000557	0.00119	CcSEcCtD
Vardenafil—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000556	0.00119	CcSEcCtD
Vardenafil—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000546	0.00117	CcSEcCtD
Vardenafil—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000543	0.00116	CcSEcCtD
Vardenafil—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000543	0.00116	CcSEcCtD
Vardenafil—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000536	0.00115	CcSEcCtD
Vardenafil—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000536	0.00115	CcSEcCtD
Vardenafil—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000535	0.00115	CcSEcCtD
Vardenafil—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000532	0.00114	CcSEcCtD
Vardenafil—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000527	0.00113	CcSEcCtD
Vardenafil—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000525	0.00112	CcSEcCtD
Vardenafil—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000518	0.00111	CcSEcCtD
Vardenafil—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000518	0.00111	CcSEcCtD
Vardenafil—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000513	0.0011	CcSEcCtD
Vardenafil—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000507	0.00109	CcSEcCtD
Vardenafil—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000506	0.00108	CcSEcCtD
Vardenafil—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000502	0.00108	CcSEcCtD
Vardenafil—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000501	0.00107	CcSEcCtD
Vardenafil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000501	0.00107	CcSEcCtD
Vardenafil—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00049	0.00105	CcSEcCtD
Vardenafil—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000489	0.00105	CcSEcCtD
Vardenafil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000481	0.00103	CcSEcCtD
Vardenafil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000481	0.00103	CcSEcCtD
Vardenafil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000477	0.00102	CcSEcCtD
Vardenafil—Rash—Formoterol—chronic obstructive pulmonary disease	0.000477	0.00102	CcSEcCtD
Vardenafil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000477	0.00102	CcSEcCtD
Vardenafil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000477	0.00102	CcSEcCtD
Vardenafil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000474	0.00102	CcSEcCtD
Vardenafil—Headache—Formoterol—chronic obstructive pulmonary disease	0.000474	0.00102	CcSEcCtD
Vardenafil—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000473	0.00101	CcSEcCtD
Vardenafil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000473	0.00101	CcSEcCtD
Vardenafil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000471	0.00101	CcSEcCtD
Vardenafil—Rash—Montelukast—chronic obstructive pulmonary disease	0.000467	0.001	CcSEcCtD
Vardenafil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000467	0.001	CcSEcCtD
Vardenafil—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000466	0.000999	CcSEcCtD
Vardenafil—Headache—Montelukast—chronic obstructive pulmonary disease	0.000464	0.000995	CcSEcCtD
Vardenafil—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.00046	0.000986	CcSEcCtD
Vardenafil—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000459	0.000983	CcSEcCtD
Vardenafil—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000458	0.000981	CcSEcCtD
Vardenafil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000454	0.000974	CcSEcCtD
Vardenafil—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000453	0.00097	CcSEcCtD
Vardenafil—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000451	0.000967	CcSEcCtD
Vardenafil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.000966	CcSEcCtD
Vardenafil—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00045	0.000965	CcSEcCtD
Vardenafil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.000965	CcSEcCtD
Vardenafil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00045	0.000963	CcSEcCtD
Vardenafil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00045	0.000963	CcSEcCtD
Vardenafil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.000959	CcSEcCtD
Vardenafil—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000441	0.000946	CcSEcCtD
Vardenafil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00044	0.000944	CcSEcCtD
Vardenafil—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000435	0.000932	CcSEcCtD
Vardenafil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000425	0.00091	CcSEcCtD
Vardenafil—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000422	0.000905	CcSEcCtD
Vardenafil—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000421	0.000903	CcSEcCtD
Vardenafil—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000419	0.000898	CcSEcCtD
Vardenafil—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000412	0.000883	CcSEcCtD
Vardenafil—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00041	0.000878	CcSEcCtD
Vardenafil—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000403	0.000864	CcSEcCtD
Vardenafil—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.0004	0.000857	CcSEcCtD
Vardenafil—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000396	0.000849	CcSEcCtD
Vardenafil—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000392	0.00084	CcSEcCtD
Vardenafil—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000389	0.000834	CcSEcCtD
Vardenafil—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00038	0.000815	CcSEcCtD
Vardenafil—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000379	0.000811	CcSEcCtD
Vardenafil—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000371	0.000794	CcSEcCtD
Vardenafil—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000368	0.000789	CcSEcCtD
Vardenafil—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000367	0.000787	CcSEcCtD
Vardenafil—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000365	0.000782	CcSEcCtD
Vardenafil—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000351	0.000751	CcSEcCtD
Vardenafil—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000344	0.000737	CcSEcCtD
Vardenafil—PDE1B—Immune System—LY96—chronic obstructive pulmonary disease	0.00034	0.00197	CbGpPWpGaD
Vardenafil—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000339	0.000726	CcSEcCtD
Vardenafil—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000338	0.000724	CcSEcCtD
Vardenafil—PDE10A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000338	0.00196	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000334	0.00194	CbGpPWpGaD
Vardenafil—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000334	0.000715	CcSEcCtD
Vardenafil—PDE1B—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000332	0.00193	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00033	0.00192	CbGpPWpGaD
Vardenafil—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000329	0.000705	CcSEcCtD
Vardenafil—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000328	0.000703	CcSEcCtD
Vardenafil—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000327	0.000701	CcSEcCtD
Vardenafil—PDE1B—Signaling by NGF—ERBB3—chronic obstructive pulmonary disease	0.000327	0.0019	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000324	0.00188	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000322	0.00187	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000322	0.00187	CbGpPWpGaD
Vardenafil—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000321	0.000687	CcSEcCtD
Vardenafil—PDE11A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000319	0.00185	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000319	0.00185	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000318	0.00185	CbGpPWpGaD
Vardenafil—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000316	0.000678	CcSEcCtD
Vardenafil—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000311	0.000666	CcSEcCtD
Vardenafil—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000311	0.000666	CcSEcCtD
Vardenafil—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00031	0.000663	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000309	0.000661	CcSEcCtD
Vardenafil—PDE11A—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000308	0.00179	CbGpPWpGaD
Vardenafil—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000307	0.000658	CcSEcCtD
Vardenafil—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000307	0.00178	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000305	0.00177	CbGpPWpGaD
Vardenafil—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000302	0.000647	CcSEcCtD
Vardenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.0003	0.00174	CbGpPWpGaD
Vardenafil—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000298	0.000638	CcSEcCtD
Vardenafil—PDE1B—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000298	0.00173	CbGpPWpGaD
Vardenafil—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000296	0.00172	CbGpPWpGaD
Vardenafil—Infection—Prednisone—chronic obstructive pulmonary disease	0.000296	0.000634	CcSEcCtD
Vardenafil—Shock—Prednisone—chronic obstructive pulmonary disease	0.000293	0.000628	CcSEcCtD
Vardenafil—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000292	0.000626	CcSEcCtD
Vardenafil—PDE6G—Disease—HDAC2—chronic obstructive pulmonary disease	0.000292	0.00169	CbGpPWpGaD
Vardenafil—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000291	0.000623	CcSEcCtD
Vardenafil—PDE11A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.00029	0.00168	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00029	0.00168	CbGpPWpGaD
Vardenafil—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000289	0.00062	CcSEcCtD
Vardenafil—PDE10A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000289	0.00168	CbGpPWpGaD
Vardenafil—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000617	CcSEcCtD
Vardenafil—PDE5A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000287	0.00167	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000287	0.00167	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000287	0.00167	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000287	0.00167	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000284	0.00165	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000279	0.00162	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000279	0.00162	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000278	0.00161	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000274	0.00159	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000274	0.00159	CbGpPWpGaD
Vardenafil—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000274	0.00159	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000272	0.00158	CbGpPWpGaD
Vardenafil—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000271	0.000581	CcSEcCtD
Vardenafil—PDE6G—Disease—KL—chronic obstructive pulmonary disease	0.000271	0.00158	CbGpPWpGaD
Vardenafil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000271	0.000581	CcSEcCtD
Vardenafil—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000269	0.00157	CbGpPWpGaD
Vardenafil—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000269	0.000577	CcSEcCtD
Vardenafil—PDE1B—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000268	0.00156	CbGpPWpGaD
Vardenafil—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000267	0.000573	CcSEcCtD
Vardenafil—PDE1B—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000265	0.00154	CbGpPWpGaD
Vardenafil—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000262	0.000562	CcSEcCtD
Vardenafil—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.000554	CcSEcCtD
Vardenafil—PDE10A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000258	0.0015	CbGpPWpGaD
Vardenafil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.000553	CcSEcCtD
Vardenafil—PDE1B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000257	0.00149	CbGpPWpGaD
Vardenafil—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000257	0.00055	CcSEcCtD
Vardenafil—PDE11A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000254	0.00147	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000249	0.00145	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000249	0.00145	CbGpPWpGaD
Vardenafil—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000245	0.000526	CcSEcCtD
Vardenafil—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000244	0.000522	CcSEcCtD
Vardenafil—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000243	0.000522	CcSEcCtD
Vardenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000243	0.00141	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—EGFR—chronic obstructive pulmonary disease	0.00024	0.00139	CbGpPWpGaD
Vardenafil—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000505	CcSEcCtD
Vardenafil—PDE1B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000234	0.00136	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000232	0.00135	CbGpPWpGaD
Vardenafil—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000228	0.00133	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000226	0.00131	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000226	0.00131	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—EGFR—chronic obstructive pulmonary disease	0.000225	0.00131	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—EGFR—chronic obstructive pulmonary disease	0.000224	0.0013	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000223	0.0013	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—EGFR—chronic obstructive pulmonary disease	0.000223	0.0013	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—EGFR—chronic obstructive pulmonary disease	0.000222	0.00129	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000222	0.00129	CbGpPWpGaD
Vardenafil—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00047	CcSEcCtD
Vardenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000218	0.00127	CbGpPWpGaD
Vardenafil—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000215	0.00125	CbGpPWpGaD
Vardenafil—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000458	CcSEcCtD
Vardenafil—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000213	0.00124	CbGpPWpGaD
Vardenafil—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000452	CcSEcCtD
Vardenafil—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00021	0.00122	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—EGFR—chronic obstructive pulmonary disease	0.000209	0.00121	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—EGFR—chronic obstructive pulmonary disease	0.000209	0.00121	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000208	0.00121	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—EGFR—chronic obstructive pulmonary disease	0.000207	0.0012	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—EGFR—chronic obstructive pulmonary disease	0.000205	0.00119	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000204	0.00119	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—EGFR—chronic obstructive pulmonary disease	0.000204	0.00119	CbGpPWpGaD
Vardenafil—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000437	CcSEcCtD
Vardenafil—PDE11A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000203	0.00118	CbGpPWpGaD
Vardenafil—PDE6G—Disease—ERBB3—chronic obstructive pulmonary disease	0.000203	0.00118	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000202	0.00117	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000199	0.00116	CbGpPWpGaD
Vardenafil—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000199	0.00116	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000198	0.00115	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000198	0.00115	CbGpPWpGaD
Vardenafil—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000422	CcSEcCtD
Vardenafil—PDE1B—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000192	0.00111	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000192	0.00111	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.00019	0.0011	CbGpPWpGaD
Vardenafil—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000406	CcSEcCtD
Vardenafil—PDE1B—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000188	0.00109	CbGpPWpGaD
Vardenafil—Rash—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000402	CcSEcCtD
Vardenafil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000402	CcSEcCtD
Vardenafil—PDE1B—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000187	0.00108	CbGpPWpGaD
Vardenafil—Headache—Prednisone—chronic obstructive pulmonary disease	0.000187	0.0004	CcSEcCtD
Vardenafil—PDE10A—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000185	0.00107	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	0.000185	0.00107	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—IL6—chronic obstructive pulmonary disease	0.000184	0.00107	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000181	0.00105	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000181	0.00105	CbGpPWpGaD
Vardenafil—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000379	CcSEcCtD
Vardenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000177	0.00103	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000175	0.00102	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—IL6—chronic obstructive pulmonary disease	0.000173	0.00101	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000173	0.001	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000172	0.001	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—IL6—chronic obstructive pulmonary disease	0.000172	0.001	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	0.000171	0.000996	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000171	0.000995	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000171	0.000994	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000171	0.000992	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000171	0.000992	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—IL6—chronic obstructive pulmonary disease	0.000171	0.000991	CbGpPWpGaD
Vardenafil—PDE6G—Disease—NOS2—chronic obstructive pulmonary disease	0.000169	0.000984	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000168	0.000973	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000164	0.000951	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	0.000162	0.000943	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000161	0.000937	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—IL6—chronic obstructive pulmonary disease	0.00016	0.000932	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—IL6—chronic obstructive pulmonary disease	0.00016	0.000932	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—IL6—chronic obstructive pulmonary disease	0.000159	0.000924	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	0.000158	0.000916	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—IL6—chronic obstructive pulmonary disease	0.000157	0.000912	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000157	0.00091	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000157	0.00091	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000156	0.000904	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000155	0.000903	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—TLR2—chronic obstructive pulmonary disease	0.000154	0.000896	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000154	0.000893	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000154	0.000892	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000153	0.000886	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.00015	0.00087	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000149	0.000867	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000149	0.000867	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000147	0.000851	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000146	0.000846	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000145	0.000844	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—KL—chronic obstructive pulmonary disease	0.000145	0.000843	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000144	0.000837	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HDAC2—chronic obstructive pulmonary disease	0.000144	0.000837	CbGpPWpGaD
Vardenafil—PDE6G—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000143	0.000829	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000142	0.000827	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	0.000142	0.000826	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	0.000142	0.000826	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.00014	0.000811	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000139	0.000809	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000139	0.000807	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000139	0.000806	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000138	0.000801	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000137	0.000796	CbGpPWpGaD
Vardenafil—PDE6G—Disease—NOS3—chronic obstructive pulmonary disease	0.000136	0.000791	CbGpPWpGaD
Vardenafil—PDE1B—Disease—KL—chronic obstructive pulmonary disease	0.000134	0.000778	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000134	0.000775	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000131	0.000761	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000129	0.00075	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.00074	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000127	0.00074	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000126	0.000733	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000124	0.000721	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CD8A—chronic obstructive pulmonary disease	0.000117	0.000679	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000115	0.000665	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000114	0.000665	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—IL6—chronic obstructive pulmonary disease	0.000109	0.000635	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000109	0.000635	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000109	0.000632	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000108	0.000626	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000108	0.000625	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000106	0.000617	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	0.000105	0.000608	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000104	0.000606	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000102	0.000593	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000101	0.000586	CbGpPWpGaD
Vardenafil—PDE1B—Disease—ERBB3—chronic obstructive pulmonary disease	0.0001	0.000583	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.0001	0.000582	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.99e-05	0.000581	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CRP—chronic obstructive pulmonary disease	9.94e-05	0.000577	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.9e-05	0.000575	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.76e-05	0.000567	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.74e-05	0.000566	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.73e-05	0.000565	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.54e-05	0.000554	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—TLR4—chronic obstructive pulmonary disease	9.53e-05	0.000554	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.38e-05	0.000545	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.38e-05	0.000545	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.3e-05	0.00054	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.25e-05	0.000538	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.25e-05	0.000538	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TGFB1—chronic obstructive pulmonary disease	9.19e-05	0.000534	CbGpPWpGaD
Vardenafil—PDE6G—Disease—TGFB1—chronic obstructive pulmonary disease	9.01e-05	0.000523	CbGpPWpGaD
Vardenafil—PDE6G—Disease—EGFR—chronic obstructive pulmonary disease	8.83e-05	0.000513	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.8e-05	0.000511	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.65e-05	0.000503	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.46e-05	0.000492	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOS2—chronic obstructive pulmonary disease	8.37e-05	0.000486	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.37e-05	0.000486	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.25e-05	0.000479	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—EGFR—chronic obstructive pulmonary disease	8.11e-05	0.000471	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.84e-05	0.000456	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.79e-05	0.000453	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.73e-05	0.000449	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.66e-05	0.000445	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TP53—chronic obstructive pulmonary disease	7.57e-05	0.00044	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	7.55e-05	0.000438	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.52e-05	0.000437	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.46e-05	0.000433	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.08e-05	0.000411	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SERPINE1—chronic obstructive pulmonary disease	7.05e-05	0.000409	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.03e-05	0.000408	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.9e-05	0.000401	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.87e-05	0.000399	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IL6—chronic obstructive pulmonary disease	6.79e-05	0.000394	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.77e-05	0.000393	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.76e-05	0.000393	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOS3—chronic obstructive pulmonary disease	6.73e-05	0.000391	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.7e-05	0.000389	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.31e-05	0.000366	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.29e-05	0.000365	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IL6—chronic obstructive pulmonary disease	6.24e-05	0.000362	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL1B—chronic obstructive pulmonary disease	6.2e-05	0.00036	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.19e-05	0.000359	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.15e-05	0.000357	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.03e-05	0.00035	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.72e-05	0.000332	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.68e-05	0.00033	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	5.65e-05	0.000328	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.2e-05	0.000302	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.19e-05	0.000302	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.17e-05	0.0003	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	5.16e-05	0.000299	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.06e-05	0.000294	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5e-05	0.00029	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.94e-05	0.000287	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.86e-05	0.000283	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.75e-05	0.000276	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.75e-05	0.000276	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—EGFR—chronic obstructive pulmonary disease	4.73e-05	0.000274	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.71e-05	0.000274	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.63e-05	0.000269	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.52e-05	0.000263	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TGFB1—chronic obstructive pulmonary disease	4.45e-05	0.000258	CbGpPWpGaD
Vardenafil—PDE1B—Disease—EGFR—chronic obstructive pulmonary disease	4.36e-05	0.000253	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.18e-05	0.000243	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.97e-05	0.000231	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.96e-05	0.00023	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.91e-05	0.000227	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.78e-05	0.00022	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.64e-05	0.000211	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL6—chronic obstructive pulmonary disease	3.63e-05	0.000211	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.45e-05	0.0002	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.4e-05	0.000197	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IL6—chronic obstructive pulmonary disease	3.35e-05	0.000195	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.12e-05	0.000181	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.06e-05	0.000177	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.66e-05	0.000154	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.63e-05	0.000153	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.57e-05	0.000149	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.4e-05	0.000139	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.35e-05	0.000136	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	2.35e-05	0.000136	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	2.24e-05	0.00013	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.21e-05	0.000128	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.84e-05	0.000107	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.82e-05	0.000106	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.69e-05	9.83e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.6e-05	9.32e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.09e-05	6.34e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.04e-05	6.06e-05	CbGpPWpGaD
